Table 5.
Group |
IL-6 (pg/mL) |
TNF-α (mg/g) |
hs-CRP (µg/L) |
|||
---|---|---|---|---|---|---|
Pretherapy | 1 week after treatment | Pretherapy | 1 week after treatment | Pretherapy | 1 week after treatment | |
Group A (n = 68) | 146.05 ± 12.05 | 55.79 ± 8.28 | 6.37 ± 2.67 | 5.19 ± 1.98 | 2.26 ± 0.46 | 1.76 ± 0.27 |
Group B (n = 62) | 146.63 ± 13.84 | 30.38 ± 5.01 | 6.28 ± 1.29 | 3.07 ± 0.94 | 2.32 ± 0.43 | 1.22 ± 0.10 |
t value | 0.255 | 20.920 | 0.241 | 7.677 | 0.766 | 14.843 |
P value | 0.799 | < 0.001 | 0.810 | < 0.001 | 0.445 | < 0.001 |
Note: IL-6, interleukin-6; TNF-α, tumor necrosis factor alpha; hs-CRP, high-sensitivity C-reactive protein.